A comprehensive literature review linking algae and antivirals determines compounds in algae may demonstrate an exceptional—and as yet untapped—potential to combat viral diseases at every point along the viral infection pathway.
A Q&A with Lauren Charles, veterinarian and PNNL data scientist, on zoonotic diseases and the role biosurveillance plays in mitigating the growing threat to global health.
PNNL combines AI and cloud computing with damage assessment tool to predict path of wildfires and quickly evaluate the impact of natural disasters, giving first responders an upper hand.
High-throughput biochemical assays targeting a vital viral protein identified one molecule out of more than 13,000 with promising antiviral activity against SARS-CoV-2.
A shoe scanner may allow people passing through security screening to keep their shoes on. PNNL built the scanner based on the same technology it used to develop airport scanners. It's licensed to Liberty Defense.
Vigorous and rapid air exchanges might not always be a good thing when it comes to levels of coronavirus particles in a multiroom building, according to a new modeling study.
One year ago, Verizon announced a partnership that made PNNL the U.S. Department of Energy’s first national laboratory with Verizon 5G ultra-wideband wireless technology.
Night shift work disrupts the natural 24-hour rhythms in the activity of certain cancer-related genes, making workers more vulnerable to damage to their DNA.
In a first-of-its-kind study, PNNL scientists are learning about how e-cigarettes can lead to changes in proteins at the molecular level that could contribute to disease or other health problems.
The Marine and Coastal Research Laboratory (MCRL), part of PNNL, in Sequim, Washington, is the U.S. Department of Energy’s only marine research facility. It has a rich history and expanding research scope.